Dermatologic Toxicity Occurring During Anti-Egfr Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review

Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2017.12.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search